|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003316,
umls-concept:C0017262,
umls-concept:C0023467,
umls-concept:C0185117,
umls-concept:C0205210,
umls-concept:C0392762,
umls-concept:C0868928,
umls-concept:C1332710,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C2911684
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2002-8-5
|
|
pubmed:abstractText |
The various epitopes of the CD34 molecule have been classified according to their different sensitivities to enzymatic cleavage by neuraminidase, chymopapain and a glycoprotease from Pasteurella haemolytica. Although monoclonal antibodies have been developed that specifically identify these epitopes, few studies have evaluated the distribution and quantitative expression of such epitopes on leukemic blasts.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
pubmed-author:AhoSergeS,
pubmed-author:BénéMarie-ChristineMC,
pubmed-author:BelM NMN,
pubmed-author:BernierMichelM,
pubmed-author:BrunetCorinneC,
pubmed-author:CamposLydiaL,
pubmed-author:CarliPaule-MariePM,
pubmed-author:DaliphardSylvieS,
pubmed-author:DeneysVéroniqueV,
pubmed-author:FalkenrodtAnnieA,
pubmed-author:FaureGilbert CGC,
pubmed-author:GerlandLucL,
pubmed-author:GirodonFrançoisF,
pubmed-author:JacobMarie-ChristineMC,
pubmed-author:KühleinEmilienneE,
pubmed-author:LeCalvezGenevièveG,
pubmed-author:MaynadiéMarcM,
pubmed-author:MoskovtchenkoPhilippeP,
pubmed-author:PhilipPatrickP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
87
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
795-803
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12161354-Acute Disease,
pubmed-meshheading:12161354-Antigens, CD34,
pubmed-meshheading:12161354-Antigens, Neoplasm,
pubmed-meshheading:12161354-Calibration,
pubmed-meshheading:12161354-Disease-Free Survival,
pubmed-meshheading:12161354-Epitopes,
pubmed-meshheading:12161354-Flow Cytometry,
pubmed-meshheading:12161354-Fluorometry,
pubmed-meshheading:12161354-Follow-Up Studies,
pubmed-meshheading:12161354-France,
pubmed-meshheading:12161354-Humans,
pubmed-meshheading:12161354-Immunophenotyping,
pubmed-meshheading:12161354-Leukemia, Myeloid,
pubmed-meshheading:12161354-Life Tables,
pubmed-meshheading:12161354-Neoplastic Stem Cells,
pubmed-meshheading:12161354-Philadelphia Chromosome,
pubmed-meshheading:12161354-Prognosis,
pubmed-meshheading:12161354-Prospective Studies,
pubmed-meshheading:12161354-Reference Standards,
pubmed-meshheading:12161354-Reproducibility of Results
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia.
|
|
pubmed:affiliation |
Service d'Hématologie biologique, CHU de Dijon, 2 Boulevard Maréchal de Lattre de Tassigny, 21034 Dijon Cedex, France. mmaynadie@chu-dijon.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
